These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 9835393)
21. Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms. Lindskog M; Svenningsson P; Fredholm BB; Greengard P; Fisone G Neuroscience; 1999; 88(4):1005-8. PubMed ID: 10336115 [TBL] [Abstract][Full Text] [Related]
22. The distribution of dynorphinergic terminals in striatal target regions in comparison to the distribution of substance P-containing and enkephalinergic terminals in monkeys and humans. Reiner A; Medina L; Haber SN Neuroscience; 1999; 88(3):775-93. PubMed ID: 10363817 [TBL] [Abstract][Full Text] [Related]
23. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms. Reid MS; Herrera-Marschitz M; Hökfelt T; Lindefors N; Persson H; Ungerstedt U Exp Brain Res; 1990; 82(2):293-303. PubMed ID: 1704847 [TBL] [Abstract][Full Text] [Related]
24. Extensive co-occurrence of substance P and dynorphin in striatal projection neurons: an evolutionarily conserved feature of basal ganglia organization. Anderson KD; Reiner A J Comp Neurol; 1990 May; 295(3):339-69. PubMed ID: 1693632 [TBL] [Abstract][Full Text] [Related]
25. Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats. Engber TM; Susel Z; Kuo S; Gerfen CR; Chase TN Brain Res; 1991 Jun; 552(1):113-8. PubMed ID: 1717109 [TBL] [Abstract][Full Text] [Related]
26. Further characterization of preproenkephalin mRNA-containing cells in the rodent globus pallidus. Hoover BR; Marshall JF Neuroscience; 2002; 111(1):111-25. PubMed ID: 11955716 [TBL] [Abstract][Full Text] [Related]
27. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--I. Effects of K(+)-depolarization, lesions and peptidase inhibition. You ZB; Nylander I; Herrera-Marschitz M; O'Connor WT; Goiny M; Terenius L Neuroscience; 1994 Nov; 63(2):415-25. PubMed ID: 7891855 [TBL] [Abstract][Full Text] [Related]
28. [Paradigm of negative feedback via long-loop in the striatal dopamine release modulation in the rat]. Bueno-Nava A; Gonzalez-Pina R; Avila-Luna A; Alfaro-Rodriguez A Rev Neurol; 2011 Mar; 52(6):371-7. PubMed ID: 21387254 [TBL] [Abstract][Full Text] [Related]
29. Neuropeptides in striato-nigral pathways. Cuello AC; Del Fiacco M; Paxinos G; Somogyi P; Priestley JV J Neural Transm; 1981; 51(1-2):83-96. PubMed ID: 6167672 [TBL] [Abstract][Full Text] [Related]
30. The neostriatal mosaic. I. Compartmental organization of projections from the striatum to the substantia nigra in the rat. Gerfen CR J Comp Neurol; 1985 Jun; 236(4):454-76. PubMed ID: 2414339 [TBL] [Abstract][Full Text] [Related]
31. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat. Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422 [TBL] [Abstract][Full Text] [Related]
32. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Gerfen CR; Young WS Brain Res; 1988 Sep; 460(1):161-7. PubMed ID: 2464402 [TBL] [Abstract][Full Text] [Related]
33. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Gerfen CR; Engber TM; Mahan LC; Susel Z; Chase TN; Monsma FJ; Sibley DR Science; 1990 Dec; 250(4986):1429-32. PubMed ID: 2147780 [TBL] [Abstract][Full Text] [Related]
34. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism. St-Hilaire M; Landry E; Lévesque D; Rouillard C Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973 [TBL] [Abstract][Full Text] [Related]
35. Nigrostriatal dopamine mediates the stimulatory effects of corticotropin releasing factor on methionine-enkephalin and dynorphin release from the rat neostriatum. Sirinathsinghji DJ; Nikolarakis KE; Reimer S; Herz A Brain Res; 1990 Aug; 526(1):173-6. PubMed ID: 1981853 [TBL] [Abstract][Full Text] [Related]
36. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors. Reid MS; O'Connor WT; Herrera-Marschitz M; Ungerstedt U Brain Res; 1990 Jun; 519(1-2):255-60. PubMed ID: 1975763 [TBL] [Abstract][Full Text] [Related]
37. Striatal nitric oxide signaling regulates the neuronal activity of midbrain dopamine neurons in vivo. West AR; Grace AA J Neurophysiol; 2000 Apr; 83(4):1796-808. PubMed ID: 10758092 [TBL] [Abstract][Full Text] [Related]
38. The effects of dopamine D-1 and D-2 receptor subtype agonists on nigrostriatal opioid dynorphin and enkephalin immunostaining in 6-hydroxydopamine lesioned rats. Jiang HK; Wang JY Chin J Physiol; 1991; 34(4):413-25. PubMed ID: 1687937 [TBL] [Abstract][Full Text] [Related]
39. Regulation of striatonigral prodynorphin peptides by dopaminergic agents. Trujillo KA; Day R; Akil H Brain Res; 1990 Jun; 518(1-2):244-56. PubMed ID: 1975215 [TBL] [Abstract][Full Text] [Related]
40. Striatopallidal Neuron NMDA Receptors Control Synaptic Connectivity, Locomotor, and Goal-Directed Behaviors. Lambot L; Chaves Rodriguez E; Houtteman D; Li Y; Schiffmann SN; Gall D; de Kerchove d'Exaerde A J Neurosci; 2016 May; 36(18):4976-92. PubMed ID: 27147651 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]